What? There?s news in peer review?

People linkurl:love to complain;http://www.the-scientist.com/article/display/23061/ about peer review. (The system is too secretive, reviewers nix their competitors? papers, etc.) Still, very little ever changes in peer review, so the same complaints circulate for years with no noticeable effect. So when something potentially system-altering happens, it?s newsworthy. Last week, Nature performed such a service by introducing a linkurl:new feature;http://blogs.nature.com/nature/peerreview/trial/

Written byAlison McCook
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
People linkurl:love to complain;http://www.the-scientist.com/article/display/23061/ about peer review. (The system is too secretive, reviewers nix their competitors? papers, etc.) Still, very little ever changes in peer review, so the same complaints circulate for years with no noticeable effect. So when something potentially system-altering happens, it?s newsworthy. Last week, Nature performed such a service by introducing a linkurl:new feature;http://blogs.nature.com/nature/peerreview/trial/ that lets readers peer review submissions to the journal at the same time the journal sends the paper to ?official? peer reviewers. The feature will continue for three months, to allow the journal to measure the value of this type of open system. Scientists who comment on the paper must identify themselves, and the journal is careful to insist that the papers are not ?in press? or endorsed by the journal. The latter point likely attempts to address criticisms that open publishing would enable any group to associate itself with Science or Nature just by sending in a paper for open review, since everyone would see the paper on the journal?s Web site. The insistence that Web reviewers sign their reviews is also interesting, given that Bernd Pulverer, editor of Nature Cell Biology, said in our February cover story on peer review that biology is too competitive to foster a system of signed reviews. ?I would find it unlikely that a junior person would write a terse, critical review for a Nobel prize-winning author,? he said. It?s unclear how much weight the journal will give to comments posted from Web users. The Nature site says editors ?may take into account? the comments when making their decision. Which means that commentators will remain in the dark as to whether editors actually listened to what they had to say, or simply added this feature to demonstrate its progressive attitude. I guess that, when it comes to peer review, there are limits to how open Nature is willing to be.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies